Oxalys Innovation

Oxalys Pharmaceuticals is developing therapies to prevent, slow, or reverse the course of brain degeneration. Parkinson’s disease and Huntington’s disease are primary focus areas, and both have a strong unmet medical need.  The company’s drug discovery platform is designed to identify small molecules that suppress the toxic effects of mutations that have a causal role in neurodegeneration.  In this way, Oxalys is finding therapeutics that inhibit the underlying causes of diseases.

http://www.oxalys.ca/index.html